DNA graphic

Search Results for: Research Portfolio

Lupus Research Alliance Appoints Albert Roy as President and Chief Executive Officer

NEW YORK, NY. August 10, 2022 – The Lupus Research Alliance (LRA) is pleased to announce the appointment of Albert Roy to President and Chief Executive Officer effective September 6, 2022. Mr. Roy currently serves as Executive Director of Lupus Therapeutics, the clinical trial affiliate of the Lupus Research Alliance. He will succeed Kenneth M. […]

Organizational Structure

Lupus Therapeutics Board of Directors: Joseph Craft, MD  is Paul B. Beeson Professor of Medicine and Professor of Immunobiology at the Yale School of Medicine, and past chief of the Section of Rheumatology at Yale. He received his degrees in chemistry as a Phi Beta Kappa graduate of University of North Carolina at Chapel Hill […]

2017-18 Research Portfolio Summary

June 5, 2018 The Lupus Research Alliance is driven by one central goal — to improve the lives of people living with the disease, today and in the long term. We believe that scientific research is the most powerful way we can achieve this goal. Further, we believe that by both pushing the limits of scientific exploration and […]

Lupus Research Alliance LuCIN Clinical Trials Network Launches Inaugural Studies

NEW YORK, NY. October 31, 2017 — The Lupus Research Alliance today announced the first clinical trials to be conducted through its Lupus Clinical Investigators Network (LuCIN) aimed at discovering new treatments for the millions of people around the globe living with lupus. Recognizing the limited treatments for lupus, LuCIN was organized, managed and is […]

New Smartphone App VALUE May Enable Lupus Patients to Report Symptoms Easily and Accurately

App developed by Lupus Research Alliance, Pfizer Inc. and Tata to be tested through non-interventional clinical trial called VALUE NEW YORK, N.Y. — The Lupus Research Alliance, the world’s largest private funder of lupus research, and Pfizer Inc., the global biopharmaceutical company, announced the start of a non-interventional clinical study that will test a custom smartphone […]